David Leslie Szekeres
CIK 1602459 · EVP, Chief Operating Officer · last filed 2025-09-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.5K
Companies
3
Total Filings
21
Lifetime Open-Market Net
-$85.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-27 | HRTX | Grant (A) | — | $0 | EDGAR |
| 2022-07-15 | HRTX | Mixed | +5,307 | -$274 | EDGAR |
| 2022-04-15 | HRTX | Mixed | +3,802 | -$12.2K | EDGAR |
| 2022-01-14 | HRTX | Mixed | +3,802 | -$16.7K | EDGAR |
| 2021-10-15 | HRTX | Mixed | +817 | -$4.6K | EDGAR |
| 2021-07-15 | HRTX | Mixed | +2,347 | $15.4K | EDGAR |
| 2021-04-15 | HRTX | Mixed | +817 | -$7.2K | EDGAR |
| 2021-01-15 | HRTX | Mixed | — | -$22.6K | EDGAR |
| 2021-01-08 | HRTX | Sell (S) | −3,571 | -$70.2K | EDGAR |
| 2014-12-04 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.